FAS and hypertensive disorder: (5) EGCG treatment reduced early aged hypertension-activated Fas-mediated Caspase-dependent apoptotic pathway, in which the evidence was based on decreases in expression levels of FasL, Fas, FADD, Caspase-8, and Caspase-3 in the cerebral cortex.